News • Blood sample
Paper test may predict Covid-19 immunity
The new test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.
Infections
News • Greenhouse gas emissions
How climate change impacts human pathogenic diseases
A comprehensive assessment of scientific literature has uncovered empirical evidence that more than 58% of human diseases caused by pathogens, such as dengue, hepatitis, pneumonia, malaria, Zika, have been aggravated by climatic hazards.
Sponsored • PJI risk mitigation
Arthroplasty: Avoiding infection and revisions in high-risk patients
The main goal of arthroplasty is to relieve pain, improve and restore joint function and recover quality of life. Periprosthetic joint infection remains a complication that has to be taken seriously.
Article • Outbreak prevention and management efforts
Infectious diseases: new challenges for EU monitoring
Avian flu, MERS, Covid-19, monkeypox: outbreaks of infectious diseases are getting more common in Europe. As a result, the EU must adapt its surveillance strategies and introduce more data-driven, interdisciplinary countermeasues.
News • Rare but dangerous infectious disease
New target to combat Melioidosis
Researchers have identified an enzyme that is a promising new therapeutic target to combat the dangerous bacterial disease melioidosis.
News • Coronavirus diagnostic distribution
Drones as a delivery system for Covid-19 tests?
Researchers have developed a new Covid-19 test distribution method that uses drones to quickly deliver at-home diagnostic tests to individuals who suspect they have Covid-19.
News • CD4-PP vs. UTI
Reducing the risk of infection for patients with urinary catheters
Indwelling catheters through the urethra often cause bacterial infections. A newly discovered synthetic peptide is a promising treatment option, even against antibiotic-resistant pathogens.
News • Protective coating
Researchers develop spray-on 'Covid shield'
A sprayable coating that can prevent the surface spread of infection from bacteria and viruses – including Covid-19 – over a sustained period has been developed by Australian researchers.
Sponsored • Covid-19 management
Rapid and robust PCR testing for infectious diseases at Innklinikum Altötting and Mühldorf
The Covid-19 pandemic has highlighted the importance of the fast and accurate diagnosis of infectious diseases in clinical settings. Harald Maier discusses the implementation of rapid molecular diagnostics in the central clinical diagnostics laboratory at Innklinikum Altötting and Mühldorf, highlighting how the use of PCR testing has benefitted the hospital during the Covid-19 pandemic.
News • Coronavirus research
How the Omicron variant dodges the immune system
By comparing the neutralisation capacity induced by the different variants of SARS-CoV-2, a team from Geneva reveals the exceptional capacity of Omicron to evade our immunity.
News • Vortex fluidic device
Next step in rapid diagnostics for infectious diseases
The speedy, high-tech method of inexpensive, accurate and high-throughput protein biomarker assay testing is being touted as a much-needed development in point-of-care (PoC) testing.
News • Immunity?
A path to better rabies vaccine design
Scientists shared one of the first high-resolution looks at the rabies virus glycoprotein in its vulnerable 'trimeric' form, revealing potential vaccine targets.
News • Unifying disease dynamics
Covid-19: New insights into recovery after severe disease
Recovery from severe Covid-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system, an international research team found.
News • Infectious disease screening
Bronchial organoids and drug discovery applications advance Covid-19 research
A research group from Kyoto developed two in vitro models to study SARS-CoV-2, and showed that they can be used for drug screening for infectious diseases including Covid-19.
News • New treatment approach
'Self-destructing' parasite: The solution for drug-resistant malaria?
Over the last 50 years, malaria parasites have developed resistance to seven drugs, but a new way to identify future antimalarials holds promise.
News • Surface treatment
Preventing deadly hospital infections without antibiotics
Hospital-acquired infections are dangerous for patients and costly for clinics. A novel surface treatment could help improve the safety of medical devices and ease the economic burden.
News • Protein malformation
Covid-19: immune reaction may cause amyloid generation
In patients with serious and long-term Covid-19, disturbed blood coagulation is often observed. Now, Swedish researchers found a connection between harmful amyloid production and Covid-19 symptoms.
News • To enter human cells
SARS-CoV-2 hijacks antiviral human proteins
SARS-CoV-2 depends on the broadly antiviral interferon-induced human transmembrane proteins , to enter human cells and replicate inside them.
News • After hospitalization
Covid: two years later, half of patients still have symptoms
Two years after infection with COVID-19, half of patients who were admitted to hospitals still have at least one symptom, according to the longest follow-up study to date.
News • HHV awaken via microRNA
Why herpes keeps coming back
Dormant herpesviruses induce their reactivation via a previously unknown cellular mechanism mediated by a viral microRNA, Würzburg researchers discovered.
News • Coronavirus census
WHO: Covid-19 pandemic claimed almost 15 million lives
In 2020 and 2021, the death toll associated with Covid-19 was approximately 14.9 million, according to the World Health Organization. However, the global distribution has been far from equal.
News • Cognitive impairment after infection
Severe Covid-19 can 'age' our brain by 20 years, study finds
Cognitive impairment as a result of severe Covid-19 is similar to that sustained between 50 and 70 years of age and is the equivalent to losing 10 IQ points, scientists found.
News • Viral aftereffects
Long Covid: Six in ten have at least one symptom one year after infection
Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.
Article • UHPLC-MS/MS analysis
Predicting Covid-19 infection severity with mass spec
Using mass spectrometry and chromatography techniques, UK researchers have developed an approach to predict infection severity among Covid-19 patients, as well as potential outcomes.
News • Global study finds increase in deaths
Why is Covid-19 more deadly on weekends?
A global analysis of nearly 6 million Covid-19 deaths finds an increase in mortality at weekends compared to weekdays. Bureaucratic and reporting delays alone do not explain this, researchers report.